While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

FDA’s requirement for truthful, balanced risk and benefit information applies to drugmakers, leaving a loophole for both ...

Analyst Michael Nedelcovych from TD Cowen maintained a Buy rating on Novo Nordisk (NVO – Research Report) and keeping the price target at ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Since its approval in mid-March of 2024, sales of Rezdiffra are increasing expediciously, reaching $62.2 million in Q3, the drug's first full quarter on the market. A mere year ago, Madrigal had no ...

A small player like Viking may also win by attracting a partner or even a company that will offer to acquire the biotech.

One shipment of suspected counterfeit Wegovy was hidden inside a Mickey Mouse puzzle for ... Chase advises consumers to only buy these drugs with a prescription from well-known pharmacies. Real weight ...

Nvidia topping Apple as the most valuable company in the world and joining the Dow Jones Industrial Average. Why Novo Nordisk and Eli Lilly are giving totally different reads on the markets for GLP-1 ...

Pfizer has a pill it's developing called danuglipron, which is in early-stage trials but has demonstrated that it's ...

Teva stock plunged Wednesday — sacrificing an earlier breakout — despite beating Wall Street's third-quarter expectations and raising its guidance.Please watch the video at Investors.com - How Novo ...